XML 74 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Stock Option Activity

The following is a summary of option activity under the Stock Incentive Plans and Inducement Plan (in thousands, except share and per share amounts):

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

Remaining

 

 

 

 

 

 

 

Number of

 

 

Exercise Price Per

 

 

Contractual Term

 

 

Aggregate Intrinsic

 

 

 

Shares

 

 

Share

 

 

(In years)

 

 

Value

 

Outstanding at December 31, 2018

 

 

4,241,833

 

 

$

6.98

 

 

 

7.02

 

 

$

471

 

Granted

 

 

2,747,700

 

 

 

2.11

 

 

 

 

 

 

 

 

 

Exercised

 

 

(2,119

)

 

 

2.01

 

 

 

 

 

 

 

1

 

Forfeited

 

 

(426,960

)

 

 

5.06

 

 

 

 

 

 

 

 

 

Canceled

 

 

(207,124

)

 

 

8.62

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

 

6,353,330

 

 

 

4.95

 

 

 

7.29

 

 

 

229

 

Exercisable at December 31, 2019

 

 

3,242,751

 

 

 

6.84

 

 

 

5.55

 

 

 

33

 

Vested or expected to vest at December 31, 2019

 

 

5,751,313

 

 

$

5.16

 

 

 

7.09

 

 

$

199

 

Schedule of Estimated Assumptions Used to Calculate Weighted-Average Grant Date Fair Value of Options Granted

The total intrinsic value of options exercised in the year ended December 31, 2019 was immaterial. The total intrinsic value of options exercised in the years ended December 31, 2018 and 2017 were $1.4 million and $0.6 million, respectively. The weighted‑average fair values of options granted in the years ended December 31, 2019, 2018, and 2017 were $1.41, $3.54, and $2.95 per share, respectively, and were calculated using the following estimated assumptions:

 

 

Year ended

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Weighted-average risk-free interest rate

 

 

1.97

%

 

 

2.67

%

 

 

1.99

%

Expected dividend yield

 

 

0.00

%

 

 

0.00

%

 

 

0.00

%

Expected volatility

 

 

78

%

 

 

68

%

 

 

60

%

Expected terms

 

6.0 years

 

 

6.0 years

 

 

6.0 years

 

Schedule of Nonvested Restricted Stock Units Activity

The following is a summary of restricted stock unit activity under the 2014 Plan (in thousands, except share and per share amounts):

 

 

 

 

 

 

 

Weighted-Average

 

 

 

Number of

 

 

Grant Date Fair

 

 

 

Shares

 

 

Value

 

Nonvested at December 31, 2018

 

 

1,198,634

 

 

$

5.04

 

Granted

 

 

589,142

 

 

 

3.23

 

Vested

 

 

(189,129

)

 

 

6.41

 

Forfeited

 

 

(303,139

)

 

 

4.33

 

Canceled

 

 

 

 

 

 

Nonvested at December 31, 2019

 

 

1,295,508

 

 

$

4.19

 

Schedule of Estimated Assumptions Used to Calculate Weighted-Average Fair Value of the Purchase Rights Granted

The fair value of the purchase rights granted under this plan was estimated on the date of grant and uses the following weighted-average assumptions, which were derived in a manner similar to those discussed in Note 2 relative to stock options:

 

 

 

Year ended

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Weighted-average risk-free interest rate

 

 

2.44

%

 

 

2.24

%

 

 

1.03

%

Expected dividend yield

 

 

0.00

%

 

 

0.00

%

 

 

0.00

%

Expected volatility

 

 

71

%

 

 

70

%

 

 

68

%

Expected terms

 

0.5 years

 

 

0.5 years

 

 

0.5 years

 

Summary of Stock-Based Compensation Expense for Stock Options Granted that was Recorded in the Company's Results of Operations

The following table summarizes the stock-based compensation expense resulting from awards granted under Stock Incentive Plans, the Inducement Plan and 2014 ESPP, that was recorded in the Company’s results of operations for the years presented (in thousands):

 

 

 

Year ended

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Cost of product revenue

 

$

365

 

 

$

803

 

 

$

125

 

Research and development

 

 

1,184

 

 

 

1,603

 

 

 

1,384

 

Selling, general and administrative

 

 

3,888

 

 

 

7,362

 

 

 

3,196

 

Total stock-based compensation expense

 

$

5,437

 

 

$

9,768

 

 

$

4,705